Both in Diagnostics
Q/C Technologies vs Insight Molecular Diagnostics
Over the past year QCLS returned −87.5% and IMDX returned −53.3%; their daily moves had a correlation of 0.08.
QCLS −87.5% IMDX −53.3%Growth of $1, one year, split-adjusted
| Metric | QCLS | IMDX |
|---|---|---|
| Price | $0.4200 | $2.86 |
| Market cap | $3.4M | $93.6M |
| Today | −3.45% | −3.38% |
| 1 month | −43.9% | −16.9% |
| 6 months | −88.9% | −45.3% |
| Year to date | −89.5% | −61.9% |
| 1 year | −87.6% | −51.7% |
| Revenue growth (YoY) | — | −53.9% |
| Gross margin | — | 65.7% |
| Net margin | — | −4711.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 56.0× |
| Net cash | $11.0M | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 297.4% | 95.3% |
| Short % of float | 12.2% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).